PubMed:23528904 / 22-35 JSONTXT

Management of stage 4S composite neuroblastoma with a MYCN-amplified nodule. MYCN amplification in neuroblastoma is usually associated with a poor prognosis. Very few cases of heterogenous MYCN amplification have been previously reported, and the clinical significance of heterogeneity is unclear. We report a neonate with an adrenal stage 4S neuroblastoma with a small focus of MYCN-amplified cells within a nonamplified background. After adrenalectomy, the patient has been observed without use of chemotherapy and has no evidence of disease progression.

projects that have annotations to this span

There is no project